MX2023012830A - Compuestos de ácido acético pirrolidinilo y tetrahidro-2h-piranilo sustituidos con triazol-piridina novedosos como antagonistas de lpa. - Google Patents

Compuestos de ácido acético pirrolidinilo y tetrahidro-2h-piranilo sustituidos con triazol-piridina novedosos como antagonistas de lpa.

Info

Publication number
MX2023012830A
MX2023012830A MX2023012830A MX2023012830A MX2023012830A MX 2023012830 A MX2023012830 A MX 2023012830A MX 2023012830 A MX2023012830 A MX 2023012830A MX 2023012830 A MX2023012830 A MX 2023012830A MX 2023012830 A MX2023012830 A MX 2023012830A
Authority
MX
Mexico
Prior art keywords
pyranyl
tetrahydro
acetic acid
triazole
novel
Prior art date
Application number
MX2023012830A
Other languages
English (en)
Spanish (es)
Inventor
Ping Chen
Hongjian Zhang
Fei Jiang
Peihua Sun
Zhenwei Cai
Original Assignee
Viva Star Biosciences Suzhou Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Viva Star Biosciences Suzhou Co Ltd filed Critical Viva Star Biosciences Suzhou Co Ltd
Publication of MX2023012830A publication Critical patent/MX2023012830A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
MX2023012830A 2021-04-30 2022-04-28 Compuestos de ácido acético pirrolidinilo y tetrahidro-2h-piranilo sustituidos con triazol-piridina novedosos como antagonistas de lpa. MX2023012830A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN2021091510 2021-04-30
PCT/US2022/026832 WO2022232459A1 (en) 2021-04-30 2022-04-28 Novel triazole-pyridine substituted pyrrolidinyl and tetrahydro-2h-pyranyl acetic acid compounds as lpa antagonists

Publications (1)

Publication Number Publication Date
MX2023012830A true MX2023012830A (es) 2024-01-19

Family

ID=81748636

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2023012830A MX2023012830A (es) 2021-04-30 2022-04-28 Compuestos de ácido acético pirrolidinilo y tetrahidro-2h-piranilo sustituidos con triazol-piridina novedosos como antagonistas de lpa.

Country Status (10)

Country Link
US (1) US20250230140A1 (cg-RX-API-DMAC7.html)
EP (1) EP4330249A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024517769A (cg-RX-API-DMAC7.html)
KR (1) KR20240044386A (cg-RX-API-DMAC7.html)
CN (1) CN117751106A (cg-RX-API-DMAC7.html)
AU (1) AU2022264579A1 (cg-RX-API-DMAC7.html)
CA (1) CA3218258A1 (cg-RX-API-DMAC7.html)
IL (1) IL308035A (cg-RX-API-DMAC7.html)
MX (1) MX2023012830A (cg-RX-API-DMAC7.html)
WO (1) WO2022232459A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023109878A1 (zh) * 2021-12-15 2023-06-22 武汉人福创新药物研发中心有限公司 三氮唑类lpar1拮抗剂及其用途
CN121773091A (zh) * 2023-09-08 2026-03-31 西藏海思科制药有限公司 杂芳环衍生物的lpar1拮抗剂及其用途
IL326963A (en) * 2023-09-08 2026-05-01 Haisco Pharmaceutical Group Co Ltd LPAR1 antagonist and its use
WO2026119206A1 (zh) * 2024-12-05 2026-06-11 海思科医药集团股份有限公司 Lpar1拮抗剂药物组合物及其在医药上的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7369125B2 (ja) * 2017-12-19 2023-10-25 ブリストル-マイヤーズ スクイブ カンパニー Lpaアンタゴニストとしてのイソキサゾールo-架橋カルバモイルシクロヘキシル酸
CA3085561A1 (en) * 2017-12-19 2019-06-27 Bristol-Myers Squibb Company Cyclohexyl acid triazole azines as lpa antagonists
ES2946657T3 (es) * 2018-09-18 2023-07-24 Bristol Myers Squibb Co Acidos ciclopentílicos como antagonistas de LPA
CN111434655A (zh) * 2019-01-15 2020-07-21 武汉朗来科技发展有限公司 溶血磷脂酸受体拮抗剂及其制备方法
KR20220024548A (ko) * 2019-06-18 2022-03-03 브리스톨-마이어스 스큅 컴퍼니 Lpa 길항제로서의 트리아졸 카르복실산
IL300525A (en) * 2020-08-11 2023-04-01 Viva Star Biosciences Ltd Triazole-pyridinyl-substituted azacyclohexyl acetic acid compounds as LPA receptor antagonists

Also Published As

Publication number Publication date
IL308035A (en) 2023-12-01
WO2022232459A1 (en) 2022-11-03
US20250230140A1 (en) 2025-07-17
EP4330249A1 (en) 2024-03-06
CN117751106A (zh) 2024-03-22
AU2022264579A1 (en) 2023-12-14
CA3218258A1 (en) 2022-11-03
JP2024517769A (ja) 2024-04-23
KR20240044386A (ko) 2024-04-04

Similar Documents

Publication Publication Date Title
MX2023001812A (es) Compuestos del acido azociclohexil acetico sustituidos por triazol-piridinilo como antagonistas del receptor lpa.
HN2011000341A (es) Compuestos derivados de sulfonamidas, composiciones farmaceuticos y proceso de preparacion de los mismos
UY32543A (es) Análogos de isoxazol-3(2h)-ona como agentes terapéuticos
UY32547A (es) Piperidinas sustituidas como antagonistas de ccr3
CO2018011105A2 (es) 6-hidroxi-4-oxo-1,4-dihidropirimidin-5-carboxamidas como agonistas del receptor de apelina (apj)
PE20170206A1 (es) Inhibidores espirociclicos sustituidos de la autotaxina
BR112022012126A2 (pt) Compostos antelmínticos compreendendo uma estrutura quinolínica
ECSP11011512A (es) Enantiómeros de compuestos de espirooxindol y sus usos como agentes terapéuticos
CU20130082A7 (es) 1,2 oxazol-8-azabiciclo[3,2,1]octano 8 il como moduladores de fxr
CO6771417A2 (es) Antagonistas del receptor de ácido lisofosfatidico y su uso en el tratamiento de fibrosis
CO6551729A2 (es) Moduladores alostericos positivos de receptores de m1 de quinolina amida
AR098576A1 (es) Producto farmacéutico
ECSP13012494A (es) Inhibidores de oxadiazol de la producción de leucotrieno.
UY34964A (es) Derivados de cromano como inhibidores del receptor transitorio potencial de la melastatina 8 (trpm8)
UY30533A1 (es) Acetamidas n-{1-[4(1-ciano-1-metil)fenil]etil}sustituidas derivadas del acido 2-(1h-bencimidazol-1il) acético
PE20181446A1 (es) Derivados de 5-etil-4-metil-pirazol-3-carboxamida con actividad como de taar
MX2021015873A (es) Un derivado de tetrahidroisoquinolina sustituido como modulador alosterico positivo de d1.
MX2023007265A (es) Inhibidores de cdk y su uso como productos farmacéuticos.
PE20181319A1 (es) Compuestos de isoindol
MX2021011576A (es) Nuevos compuestos y composiciones farmaceuticas de los mismos para el tratamiento de trastornos inflamatorios.
MX2021011574A (es) Nuevos compuestos y composiciones farmaceuticas de los mismos para el tratamiento de trastornos inflamatorios.
PH12013501462A1 (en) Novel benzodioxole piperazine compounds
PE20142399A1 (es) Compuestos de pirazol como inhibidores de sglt1
PY22111032A (es) Inhibidores de dhodh que contienen un bioisostero de acido carboxilico
PH12013500330A1 (en) Disubstituted tetrahydofuranyl compounds as antagonists of the bradykinin b1 receptor